Meiji Seika Kaisha, Ltd.

Meiji Seika Kabushiki Kaisha

Schering Aktiengesellschaft

Yasuyuki Ichimaru

Fukio Konno

Taiichiro Imanishi

Aiko Sawa

Burton G Christensen

Arthur A Patchett

Takashi Tsuruoka

Seiji Shibahara

Helmut Wachtel

Kiyoaki Katano

Toshiro Sasaki

Tsuneo Okonogi

Eiki Shitara

Hiroko Ogino

Yoshimasa Fukuda

Michihiro Fujiwara

Tomoya Machinami

Naomi Osada

Shokichi Ohuchi

Toru Nishikawa

Keiji Wada

Tsuneyuki Yamamoto

Showa Ueki

Toyakazu Hiranuma

Jun Nagura

Hiromi Watanabe

Takashi Egawa

Seiji Tsutsumni

Yuuko Nakatani

Remedies for spinocerebellar degeneration or compositions for treating the same which contain as the active ingredient one or more members selected from among D-cycloserine, D-serine esters, D-serine and salts thereof. A method for treating spincerebellar degeneration which comprises administering to a patient with this disease in an efficacious dose of one or more members selected from among D-cycloserine, D-serine esters, D-serine and salts thereof.

Remedies for spinocerebellar ataxia and compositions for treating spinocerebellar ataxia

Antipsychotic benzoisothiazolyl piperazine derivatives

The invention relates to derivatives of pyrrolidin-2-ylcarbonylheterocyclic compound of the general formula ##STR1## in which R.sup.1 represents C.sub.1-6 alkyl, C.sub.1-20 cycloalkyl, aryl or heteroaryl,

Derivatives of pyrrolidin-2-ylcarbonylheterocyclic compounds

Pyridine derivatives having angiotensin II antagonism

The invention relates to a method of treating dementia, such as cerebro-vascular dementia, for example, multiple infarct dementia and amyloid angiopathic dementia, cerebro-parenchymatous dementia, such as Alzheimer's dementia and Pick's disease, and dementia caused by brain tumor, hydrocephalus, hepatic meningitis, cerebral trauma, or cerebral function disorders, comprising administering rolipram.

Anti-dementia drug

Growing community of inventors

Yokohama, Japan

Yasuyuki Ichimaru